Policy and Advocacy
EORTC and ECPC reply to the public consultation on the European Commission's Summary of Clinical Trial Results for Laypersons
ECPC together with the European Organisation for Research and Treatment of Cancer (EORTC) contributed to the European Commission's public consultation on "Risk proportionate approaches in clinical trials" by providing joint reply to the Summary of Clinical Trial Results for Laypersons.
EORTC and ECPC are both interested in bringing timely and accurate clinical trials information to cancer patients so that they can make informed decisions. In view of their common interests in cancer patient information and education in clinical trials and cancer research, they decided to jointly comment to present consultation to show their common commitment.